Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Lebanon National Drugs Database

This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health
 
You can search in the form below for information related to drugs including Subsidy percentage

Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
 
    ...
    131
    ...
ATC Name B/G Ingredients Dosage Form Price
L01XG01 BORTEZOMIB SPC G Bortezomib - 3.5mg 3.5mg Injectable powder for solution 24,002,843 L.L
L01XG01 BROTEX MS G Bortezomib - 3.5mg 3.5mg Injectable powder for solution 921,914 L.L
L01XG01 VELZOME G Bortezomib - 3.5mg 3.5mg Injectable powder for solution 4,283,403 L.L
L01XG01 VELCADE B Bortezomib - 3.5mg 3.5mg Injectable lyophilised powder for solution 35,212,136 L.L
L01XG01 BORTEZOMIB ACCORD G Bortezomib - 3.5mg 3.5mg Injectable powder for solution 22,054,185 L.L
L01XG01 BROTEX MS G Bortezomib - 3.5mg 3.5mg Injectable powder for solution 56,205,905 L.L
L01XG01 BORTEZOMIB NEAPOLIS G Bortezomib - 3.5mg 3.5mg Injectable lyophilised powder for solution 35,076,021 L.L
L01XG01 VELZOME G Bortezomib - 3.5mg 3.5mg Injectable powder for solution 26,180,966 L.L
L01XG01 BORTEZOMIB GP PHARM G Bortezomib - 3.5mg 3.5mg Injectable powder for solution 21,928,334 L.L
L01XG02 KYPROLIS B Carfilzomib - 60mg 60mg Injectable powder for solution 1,813,283 L.L
L01XG02 KYPROLIS B Carfilzomib - 60mg 60mg Injectable powder for solution 110,549,631 L.L
L01XG03 NINLARO B Ixazomib - 4mg 4mg Capsule, hard 7,358,577 L.L
L01XG03 NINLARO B Ixazomib - 3mg 3mg Capsule, hard 7,358,577 L.L
L01XG03 NINLARO B Ixazomib - 2.3mg 2.3mg Capsule, hard 7,358,577 L.L
L01XG03 NINLARO B Ixazomib - 4mg 4mg Capsule, hard 448,627,161 L.L
L01XG03 NINLARO B Ixazomib - 3mg 3mg Capsule, hard 448,627,161 L.L
L01XG03 NINLARO B Ixazomib - 2.3mg 2.3mg Capsule, hard 448,627,161 L.L
L01XJ01 ERIVEDGE B Vismodegib - 150mg 150mg Capsule 7,633,168 L.L
L01XJ01 ERIVEDGE B Vismodegib - 150mg 150mg Capsule 465,368,012 L.L
L01XK01 LYNPARZA B Olaparib - 100mg 100mg Tablet, film coated 4,331,050 L.L
L01XK01 LYNPARZA B Olaparib - 150mg 150mg Tablet, film coated 4,331,050 L.L
L01XK01 LYNPARZA B Olaparib - 100mg 100mg Tablet, film coated 264,049,193 L.L
L01XK01 LYNPARZA B Olaparib - 150mg 150mg Tablet, film coated 264,049,193 L.L
L01XK04 TALZENNA B Talazoparib - 1mg 1mg Capsule 6,585,777 L.L
L01XK04 TALZENNA B Talazoparib - 0.25mg 0.25mg Capsule 2,195,248 L.L
L01XK04 TALZENNA B Talazoparib - 1mg 1mg Capsule 401,512,167 L.L
L01XK04 TALZENNA B Talazoparib - 0.25mg 0.25mg Capsule 133,836,699 L.L
L01XX02 ERWINASE BioTech Erwinia L-asparaginase - 10,000IU 10,000IU Injectable lyophilised powder for solution 4,446,519 L.L
L01XX02 SPECTRILA BioTech Asparaginase, recombinant - 10,000IU 10,000IU Injectable powder for concentrate for solution 21,370,813 L.L
L01XX02 ERWINASE BioTech Erwinia L-asparaginase - 10,000IU 10,000IU Injectable lyophilised powder for solution 271,088,947 L.L
    ...
    131
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2024